2. HEAD/NECK OF THE SKIN ANALYTIC vs. NON-ANALYTIC by YEAR N = 1800

3. Brain-CNS, Benign/Borderline – 95 (2.64%) Brain, Malignant – 135 (3.75) Oral Cavity & Pharynx – 144 (4.00%) Esophagus – 35 (0.97%) Lung & Bronchus – 219 (6.09%) Stomach – 50(1.39%) Pancreas – 232 (6.45%) Colon & Rectum – 138 (3.84%) Kidney & Renal Pelvis – 155 (4.31%) Urinary Bladder – 163 (4.53%) Prostate – 1124 (31.26%) Non-Hodgkin Lymphoma – 100 (2.78%) Melanoma of the Skin – 193 (5.37%) Leukemia – 147 (4.09%) All other sites – 666 (18.52%) Brain-CNS, Benign/Borderline – 152 (5.43%) Brain, Malignant – 111 (3.96) Oral Cavity & Pharynx – 67 (2.39) Thyroid – 282 (10.07%) Stomach – 28 (1.00%) Lung & Bronchus – 226 (8.07%) Breast – 555 (19.82%) Pancreas – 196 (7.00%) Kidney & Renal Pelvis – 86 (3.07%) Corpus Uteri – 88 (3.14%) Colon & Rectum – 106 (3.79%) Non-Hodgkin Lymphoma – 94 (3.36%) Melanoma of the skin – 159 (5.68%) Leukemia – 99 (3.54%) All other sites – 551 (19.67%) Males 3596 Females 2800

4. HEAD/NECK OF THE SKIN ANALYTIC vs. NON-ANALYTIC by YEAR N = 1800